Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design
- Autores
- Boechi, Leonardo; de Oliveira, César Augusto F.; Da Fonseca, Isabel; Kizjakina, Karina; Sobrado, Pablo; Tanner, John J.; McCammon, J. Andrew
- Año de publicación
- 2013
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease that represents one of the major health challenges of the Latin American countries. Successful efforts were made during the last few decades to control the transmission of this disease, but there is still no treatment for the 10 million adults in the chronic phase of the disease. In T. cruzi, as well as in other pathogens, the flavoenzyme UDP-galactopyranose mutase (UGM) catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, a precursor of the cell surface β-galactofuranose that is involved in the virulence of the pathogen. The fact that UGM is not present in humans makes inhibition of this enzyme a good approach in the design of new Chagas therapeutics. By performing a series of computer simulations of T. cruzi UGM in the presence or absence of an active site ligand, we address the molecular details of the mechanism that controls the uptake and retention of the substrate. The simulations suggest a modular mechanism in which each moiety of the substrate controls the flexibility of a different protein loop. Furthermore, the calculations indicate that interactions with the substrate diphosphate moiety are especially important for stabilizing the closed active site. This hypothesis is supported with kinetics measurements of site-directed mutants of T. cruzi UGM. Our results extend our knowledge of UGM dynamics and offer new alternatives for the prospective design of drugs.
Fil: Boechi, Leonardo. University Of California At San Diego; Estados Unidos
Fil: de Oliveira, César Augusto F.. University Of California At San Diego; Estados Unidos
Fil: Da Fonseca, Isabel. Virginia Tech University; Estados Unidos
Fil: Kizjakina, Karina. Virginia Tech University; Estados Unidos
Fil: Sobrado, Pablo. Virginia Tech University; Estados Unidos
Fil: Tanner, John J.. University Of Missouri; Estados Unidos
Fil: McCammon, J. Andrew. University Of California At San Diego; Estados Unidos - Materia
-
Udp-Galactopyranose Mutase
Ugm
Molecular Dynamics
Accelerated Molecular Dynamics - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/15880
Ver los metadatos del registro completo
id |
CONICETDig_8aa83ff4d8764cc3c3468127f66d4e47 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/15880 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug designBoechi, Leonardode Oliveira, César Augusto F.Da Fonseca, IsabelKizjakina, KarinaSobrado, PabloTanner, John J.McCammon, J. AndrewUdp-Galactopyranose MutaseUgmMolecular DynamicsAccelerated Molecular Dynamicshttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease that represents one of the major health challenges of the Latin American countries. Successful efforts were made during the last few decades to control the transmission of this disease, but there is still no treatment for the 10 million adults in the chronic phase of the disease. In T. cruzi, as well as in other pathogens, the flavoenzyme UDP-galactopyranose mutase (UGM) catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, a precursor of the cell surface β-galactofuranose that is involved in the virulence of the pathogen. The fact that UGM is not present in humans makes inhibition of this enzyme a good approach in the design of new Chagas therapeutics. By performing a series of computer simulations of T. cruzi UGM in the presence or absence of an active site ligand, we address the molecular details of the mechanism that controls the uptake and retention of the substrate. The simulations suggest a modular mechanism in which each moiety of the substrate controls the flexibility of a different protein loop. Furthermore, the calculations indicate that interactions with the substrate diphosphate moiety are especially important for stabilizing the closed active site. This hypothesis is supported with kinetics measurements of site-directed mutants of T. cruzi UGM. Our results extend our knowledge of UGM dynamics and offer new alternatives for the prospective design of drugs.Fil: Boechi, Leonardo. University Of California At San Diego; Estados UnidosFil: de Oliveira, César Augusto F.. University Of California At San Diego; Estados UnidosFil: Da Fonseca, Isabel. Virginia Tech University; Estados UnidosFil: Kizjakina, Karina. Virginia Tech University; Estados UnidosFil: Sobrado, Pablo. Virginia Tech University; Estados UnidosFil: Tanner, John J.. University Of Missouri; Estados UnidosFil: McCammon, J. Andrew. University Of California At San Diego; Estados UnidosWiley2013-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/15880Boechi, Leonardo; de Oliveira, César Augusto F.; Da Fonseca, Isabel; Kizjakina, Karina; Sobrado, Pablo; et al.; Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design; Wiley; Protein Science; 22; 11; 11-2013; 1490-15010961-8368enginfo:eu-repo/semantics/altIdentifier/doi/10.1002/pro.2332info:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1002/pro.2332/abstractinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:33:01Zoai:ri.conicet.gov.ar:11336/15880instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:33:01.302CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design |
title |
Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design |
spellingShingle |
Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design Boechi, Leonardo Udp-Galactopyranose Mutase Ugm Molecular Dynamics Accelerated Molecular Dynamics |
title_short |
Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design |
title_full |
Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design |
title_fullStr |
Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design |
title_full_unstemmed |
Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design |
title_sort |
Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design |
dc.creator.none.fl_str_mv |
Boechi, Leonardo de Oliveira, César Augusto F. Da Fonseca, Isabel Kizjakina, Karina Sobrado, Pablo Tanner, John J. McCammon, J. Andrew |
author |
Boechi, Leonardo |
author_facet |
Boechi, Leonardo de Oliveira, César Augusto F. Da Fonseca, Isabel Kizjakina, Karina Sobrado, Pablo Tanner, John J. McCammon, J. Andrew |
author_role |
author |
author2 |
de Oliveira, César Augusto F. Da Fonseca, Isabel Kizjakina, Karina Sobrado, Pablo Tanner, John J. McCammon, J. Andrew |
author2_role |
author author author author author author |
dc.subject.none.fl_str_mv |
Udp-Galactopyranose Mutase Ugm Molecular Dynamics Accelerated Molecular Dynamics |
topic |
Udp-Galactopyranose Mutase Ugm Molecular Dynamics Accelerated Molecular Dynamics |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease that represents one of the major health challenges of the Latin American countries. Successful efforts were made during the last few decades to control the transmission of this disease, but there is still no treatment for the 10 million adults in the chronic phase of the disease. In T. cruzi, as well as in other pathogens, the flavoenzyme UDP-galactopyranose mutase (UGM) catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, a precursor of the cell surface β-galactofuranose that is involved in the virulence of the pathogen. The fact that UGM is not present in humans makes inhibition of this enzyme a good approach in the design of new Chagas therapeutics. By performing a series of computer simulations of T. cruzi UGM in the presence or absence of an active site ligand, we address the molecular details of the mechanism that controls the uptake and retention of the substrate. The simulations suggest a modular mechanism in which each moiety of the substrate controls the flexibility of a different protein loop. Furthermore, the calculations indicate that interactions with the substrate diphosphate moiety are especially important for stabilizing the closed active site. This hypothesis is supported with kinetics measurements of site-directed mutants of T. cruzi UGM. Our results extend our knowledge of UGM dynamics and offer new alternatives for the prospective design of drugs. Fil: Boechi, Leonardo. University Of California At San Diego; Estados Unidos Fil: de Oliveira, César Augusto F.. University Of California At San Diego; Estados Unidos Fil: Da Fonseca, Isabel. Virginia Tech University; Estados Unidos Fil: Kizjakina, Karina. Virginia Tech University; Estados Unidos Fil: Sobrado, Pablo. Virginia Tech University; Estados Unidos Fil: Tanner, John J.. University Of Missouri; Estados Unidos Fil: McCammon, J. Andrew. University Of California At San Diego; Estados Unidos |
description |
Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease that represents one of the major health challenges of the Latin American countries. Successful efforts were made during the last few decades to control the transmission of this disease, but there is still no treatment for the 10 million adults in the chronic phase of the disease. In T. cruzi, as well as in other pathogens, the flavoenzyme UDP-galactopyranose mutase (UGM) catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, a precursor of the cell surface β-galactofuranose that is involved in the virulence of the pathogen. The fact that UGM is not present in humans makes inhibition of this enzyme a good approach in the design of new Chagas therapeutics. By performing a series of computer simulations of T. cruzi UGM in the presence or absence of an active site ligand, we address the molecular details of the mechanism that controls the uptake and retention of the substrate. The simulations suggest a modular mechanism in which each moiety of the substrate controls the flexibility of a different protein loop. Furthermore, the calculations indicate that interactions with the substrate diphosphate moiety are especially important for stabilizing the closed active site. This hypothesis is supported with kinetics measurements of site-directed mutants of T. cruzi UGM. Our results extend our knowledge of UGM dynamics and offer new alternatives for the prospective design of drugs. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-11 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/15880 Boechi, Leonardo; de Oliveira, César Augusto F.; Da Fonseca, Isabel; Kizjakina, Karina; Sobrado, Pablo; et al.; Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design; Wiley; Protein Science; 22; 11; 11-2013; 1490-1501 0961-8368 |
url |
http://hdl.handle.net/11336/15880 |
identifier_str_mv |
Boechi, Leonardo; de Oliveira, César Augusto F.; Da Fonseca, Isabel; Kizjakina, Karina; Sobrado, Pablo; et al.; Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design; Wiley; Protein Science; 22; 11; 11-2013; 1490-1501 0961-8368 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1002/pro.2332 info:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1002/pro.2332/abstract |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley |
publisher.none.fl_str_mv |
Wiley |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614344927608832 |
score |
13.070432 |